Progesterone therapy increases free thyroxine levels--data from a randomized placebo-controlled 12-week hot flush...

Area of Science:

• Endocrinology
• Women's Health
• Reproductive Medicine

Background:

• Thyroid hormones and progesterone play vital roles in metabolism and core body temperature regulation.
• Both hormones are essential during pregnancy and influence physiological processes.
• Menopausal hormone changes can impact thyroid function and overall well-being.

Purpose of the Study:

• To investigate the effects of progesterone therapy on thyroid hormone levels in postmenopausal women.
• To determine if oral micronized progesterone influences thyroid-stimulating hormone (TSH), FreeT3, and FreeT4 levels.
• To compare thyroid physiology changes between women receiving progesterone and those on placebo.

Main Methods:

• A post hoc analysis of a 12-week, randomized, placebo-controlled trial involving oral micronized progesterone (300 mg/d).
• Participants were healthy, postmenopausal women with no cardiovascular risks, experiencing vasomotor symptoms (VMS).
• Thyroid function tests (TSH, FreeT3, FreeT4) were assessed at baseline and 12 weeks.

Main Results:

• No significant correlation was found between VMS severity and thyroid hormone levels.
• Women receiving progesterone showed a trend towards lower TSH levels (P=0.06) and significantly higher FreeT4 levels (P=0.02) compared to placebo.
• Analysis revealed a statistically significant increase in FreeT4 levels in the progesterone group (P=0.04).

Conclusions:

• Progesterone therapy was associated with a significant increase in FreeT4 levels in postmenopausal women.
• The clinical implications of elevated FreeT4 due to progesterone require further research.
• This finding emerged from a randomized controlled trial investigating VMS treatment.